Physician profile
Glenn E Harnett
NPI 1982644407
$113,074.40
in general payments reported to CMS, 2019-2025
12 companies · $3,542 in 2025
The $3,542 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2021: $27K · 2022: $19K · 2023: $28K · 2024: $17K · 2025: $3,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $6,852 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,060.38 |
| Travel and Lodging | $6,851.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Food and Beverage | $175.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visby Medical, INC. | $44,001.76 | 2022-2023 | Visby Medical Sexual Health Click Test |
| Biofire Diagnostics, LLC | $26,975.29 | 2021-2024 | Biofire Spotfire Respiratory (R) Panel |
| Melinta Therapeutics, LLC | $18,508.04 | 2019 | |
| Abbott Laboratories | $14,583.30 | 2023-2025 | Id Now Instrument |
| Biomerieux INC | $6,606.01 | 2024 | |
| Roche Molecular Systems, INC. | $2,400.00 | 2024 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Harnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.